Market Cap: $2.71M
AI
Aethlon Medical, Inc.
AEMD
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $2.71M
Aethlon Medical, Inc. progresses significantly in its Australian oncology study, entering the third and final dosing cohort to evaluate the efficacy of its Hemopurifier treatment for cancer patients.…
Aethlon Medical's Hemopurifier Trial Accelerates Towards Promising Outcomes Aethlon Medical, Inc., a biotech firm specializing in innovative therapies, recently announces a significant milestone conce…
Aethlon Medical Explores Strategic Opportunities Amid Promising Clinical Developments Aethlon Medical, Inc., a San Diego-based clinical-stage medical device company, actively explores strategic opport…
Aethlon Medical's Strategic Growth: Exploring Partnerships for Future Developments Aethlon Medical, Inc., a San Diego-based clinical-stage medical device company, is taking significant steps toward it…
Hemopurifier advances toward broader oncology and extracellular vesicle applications Aethlon Medical is advancing its Hemopurifier program with active enrollment and treatment in Cohort 2 of an Austra…
Aethlon accelerates Hemopurifier development in oncology and extracellular vesicle science Hemopurifier advances in Australian oncology study and EV modulation Aethlon Medical is advancing clinical de…
Aethlon Medical Secures Funding to Advance Innovative Therapies Aethlon Medical, Inc. focuses on developing therapies for cancer and life-threatening infectious diseases. The company recently announce…
Aethlon Medical Advances Treatment for Long COVID with Hemopurifier Aethlon Medical, Inc. is making significant strides in the fight against Long COVID, a debilitating condition affecting millions of…
Aethlon Medical's Position in the Evolving Healthcare Landscape Aethlon Medical, a leader in developing innovative therapeutic devices, stands at the forefront of addressing critical healthcare challe…
### Aethlon Medical's Upcoming Earnings Report: A Pivotal Moment in Biotech Innovation Aethlon Medical is on the brink of announcing its quarterly earnings on November 12, 2025, a development that has…
Aethlon Medical Secures Funding to Propel Innovative Therapeutics Aethlon Medical, Inc., a clinical-stage therapeutic company based in San Diego, is making strides in the medical field with its recent…
Aethlon Medical's Strategic Funding Initiative to Enhance Clinical Development Aethlon Medical, Inc., a clinical-stage therapeutic company based in San Diego, has embarked on a significant funding ini…
Aethlon Medical Secures Funding for Expanding Clinical Initiatives Aethlon Medical, Inc., a clinical-stage therapeutic company based in San Diego, announces a significant public offering aimed at enha…
Aethlon Medical Advances Its Financial Strategy Through New Securities Offering Aethlon Medical Inc. is currently making significant strides in its financial strategy with the announcement of a new se…
Aethlon Medical Advances Funding Strategy to Bolster Therapeutic Innovations Aethlon Medical Inc. is actively pursuing a new securities offering to enhance its funding capabilities, a strategic move t…
Aethlon Medical: Strategic Funding to Propel Innovation in Therapeutic Devices Aethlon Medical Inc. is actively advancing its strategic initiatives through a newly announced securities offering aimed…
Aethlon Medical Advances Cancer Treatment Trials Amid Operational Efficiency Improvements Aethlon Medical, Inc. (Nasdaq: AEMD) makes notable strides in its clinical trials for the Hemopurifier® device…
Aethlon Medical Advances in Cancer Treatment with Hemopurifier® Trial Success Aethlon Medical, Inc. is making notable strides in cancer treatment through its ongoing trials of the Hemopurifier®, parti…
Aethlon Medical Advances in Hemopurifier® Cancer Trial Amid Operational Efficiency Gains Aethlon Medical, Inc. (Nasdaq: AEMD) makes notable strides in its clinical development as it successfully compl…
Advancements in Medical Technology: Aethlon Medical's Role in the Fight Against Infectious Diseases Aethlon Medical, a company specializing in innovative medical technologies, continues to make signif…
Aethlon Medical's Innovative ADAPT Platform: A Game Changer in Infectious Disease Treatment Aethlon Medical (AEMD) stands on the cusp of a significant moment as it prepares to release its quarterly ea…
Aethlon Medical: Pioneering Infectious Disease Solutions with the ADAPT Platform Aethlon Medical (AEMD) is at a critical juncture as it prepares to release its quarterly earnings report on June 26, 20…
Aethlon Medical’s Focus on Innovative Therapeutics Ahead of Earnings Report Aethlon Medical (AEMD) is on the verge of releasing its quarterly earnings report on June 26, 2025, a significant event that…